Zip. If developing, getting FDA approval and making a profit selling either a Statin / Vascepa combo or an MND-2119 once a day IPE product was as easy to do as you seem to think it is ....why hasn't AMRN done either yet. ?
The benefits of a once a day IPE product ( MND-2119 ) are several as poster JR mentioned ...and obvious . Kiwi
KIWI...Its clear that there is disagreement on this important subject...Perhaps Holt could make some comments on this topic to clear some points up for all interested in Amarin.
News 
Market Data 
Discover 
